Healthcare -
Biotechnology - NASDAQ - US
$ 1.1704
-2.47 %
$ 2.39 M
Market Cap
-0.09
P/E
Price Target
Average
412.65%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
100.00%
Net Income
Estimate
95.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Dermata Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for DRMA of $6 , with forecasts ranging from
a
low of
$6 to a high of $6 .
DRMA Lowest Price Target
Wall Street Target
6 USD
412.65%
DRMA Average Price Target
Wall Street Target
6 USD
412.65%
DRMA Highest Price Target
Wall Street Target
6 USD
412.65%
REVENUE FORECAST
Revenue Forecast Chart DRMA
EBIT FORECAST
EBIT Forecast Chart DRMA
NET INCOME FORECAST
Net Income Chart DRMA